A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

NCT06835972 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma
Translocation Renal Cell Carcinoma

Interventions

DRUG: Abemaciclib
DRUG: Cabozantinib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]